Company intelligence / Profile preview

Axion BioSystems

Atlanta, Georgia, United States

Ownership: Private
Employees: ~142
Development stage: Other

Overview

Axion BioSystems develops and markets advanced real-time live-cell analysis tools used in basic research, drug discovery, and assay development; their systems contribute to progress in areas including neurology, cardiology, immuno-oncology, stem cell research, and cell/gene therapy. Their products are extensively used in biopharma and academia for understanding cell function and supporting preclinical research[1][2][3][4][5].

Industry: Non-Drug Biotech

Partnerships

Corning (exclusive distribution of Corning Cell Counter)[5]

Beyond the preview

Go deeper on Axion BioSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axion BioSystems.

Explore the full profile